ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 377 filers reported holding ENCOMPASS HEALTH CORP in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $529,325 | -4.4% | 6,170 | -8.0% | 0.08% | -5.8% |
| Q1 2024 | $553,811 | +23.6% | 6,706 | -0.1% | 0.09% | +10.3% |
| Q4 2023 | $448,122 | +7.1% | 6,716 | +7.8% | 0.08% | -6.0% |
| Q3 2023 | $418,537 | +4.4% | 6,231 | +5.2% | 0.08% | +2.5% |
| Q2 2023 | $400,885 | +25.7% | 5,921 | +0.5% | 0.08% | +22.7% |
| Q1 2023 | $318,834 | +19.1% | 5,893 | +31.6% | 0.07% | +15.8% |
| Q4 2022 | $267,785 | +31.3% | 4,477 | +23.1% | 0.06% | +18.8% |
| Q2 2022 | $204,000 | -32.9% | 3,637 | -15.1% | 0.05% | -20.0% |
| Q1 2022 | $304,000 | +18.8% | 4,282 | +9.2% | 0.06% | +25.0% |
| Q4 2021 | $256,000 | -16.9% | 3,922 | -4.4% | 0.05% | -23.8% |
| Q3 2021 | $308,000 | +0.3% | 4,101 | +4.2% | 0.06% | 0.0% |
| Q2 2021 | $307,000 | -5.0% | 3,934 | -0.4% | 0.06% | -10.0% |
| Q1 2021 | $323,000 | +2.5% | 3,948 | +3.6% | 0.07% | -10.3% |
| Q4 2020 | $315,000 | – | 3,811 | +3.4% | 0.08% | – |
| Q3 2020 | $0 | -100.0% | 3,684 | +1.7% | 0.00% | -100.0% |
| Q2 2020 | $224,000 | 0.0% | 3,624 | +12.3% | 0.07% | +3.1% |
| Q4 2019 | $224,000 | – | 3,228 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 8 KNOTS MANAGEMENT, LLC | 977,427 | $83,853,462 | 8.10% |
| Paradice Investment Management LLC | 247,041 | $21,193,647 | 3.75% |
| Orchard Capital Management, LLC | 143,105 | $12,276,978 | 3.71% |
| BERNZOTT CAPITAL ADVISORS | 83,708 | $7,181,333 | 3.31% |
| 1492 Capital Management LLC | 59,728 | $5,124,065 | 2.90% |
| Integral Health Asset Management, LLC | 300,000 | $25,737,000 | 2.44% |
| REINHART PARTNERS, LLC. | 657,490 | $56,406,050 | 2.34% |
| Leeward Investments, LLC - MA | 556,625 | $47,752,870 | 2.19% |
| Copeland Capital Management, LLC | 1,272,117 | $109,134,918 | 2.04% |
| Perbak Capital Partners LLP | 78,451 | $6,730,311 | 1.99% |